Stay updated on CAR-T Therapy for Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the CAR-T Therapy for Multiple Myeloma Clinical Trial page.

Latest updates to the CAR-T Therapy for Multiple Myeloma Clinical Trial page
- Check14 days agoChange DetectedAdded related topics 'Multiple myeloma' and 'MedlinePlus Genetics' and updated the page revision from v3.3.1 to v3.3.2.SummaryDifference0.2%

- Check21 days agoChange DetectedPublication note updated to indicate that PubMed entries are automatically filled and may not all pertain to the study. The page revision tag was updated to Revision: v3.3.1.SummaryDifference0.1%

- Check29 days agoChange DetectedNon-significant deletions remove a government funding notice and related topic links from the study record page. Core study information, such as title, conditions, and locations, remains unchanged.SummaryDifference0.4%

- Check43 days agoChange DetectedUpdates are limited to administrative timestamps and QC statuses (e.g., last update posted 2025-07-30) with no changes to core trial content such as eligibility criteria, endpoints, or locations—To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check50 days agoChange DetectedAdded related topics tags: Multiple myeloma and MedlinePlus Genetics. Core study details and eligibility criteria remain unchanged.SummaryDifference0.1%

- Check71 days agoChange DetectedUpdate to version v3.2.0 with a new topic (Multiple myeloma) and a government operating status notice; removes the previous v3.1.0 reference.SummaryDifference1%

Stay in the know with updates to CAR-T Therapy for Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAR-T Therapy for Multiple Myeloma Clinical Trial page.